22.2%→46.8%

of burn pit list claims granted for all veterans vs. in decisions that name Kuwait

26.6%→42.2%

of PTSD claims granted for all veterans vs. in decisions that record military sexual trauma

23.7%→66.0%

of herbicide-list claims granted for all veterans vs. in decisions that name Thailand

22.2%→43.8%

of burn pit list claims granted for all veterans vs. in decisions that name Iraq

37.3%→42.5%

of Parkinson's disease claims granted for all veterans vs. in decisions that name Vietnam

22.2%→41.1%

of burn pit list claims granted for all veterans vs. in decisions that name Afghanistan

8.4%→69.5%

of migraine claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

23.7%→35.6%

of herbicide-list claims granted for all veterans vs. in decisions about service involving Cambodia

30.8%→48.5%

of coronary artery disease claims granted overall vs. in decisions that mention Agent Orange or other herbicides

12.4%→29.3%

of hip claims secondary to a knee granted, 2018–2019 vs 2024–2025

24.5%→35.5%

of PTSD decisions granted, 2018–2019 compared with 2024–2025

21.3%→33.2%

of sleep apnea decisions granted, 2018 to 2019 versus 2024 to 2025

12.3%→24.6%

of TBI claims granted for all veterans vs. in decisions that record combat service

20.0%→42.4%

of diabetes claims granted overall vs. in decisions that mention Agent Orange or other herbicides

7.9%→67.7%

of foot claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

23.7%→41.0%

of herbicide-list claims granted for all veterans vs. in decisions that name Laos

5.4%→71.3%

of ankle claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

26.6%→46.6%

of PTSD claims granted for all veterans vs. in decisions that record combat service

20.1%→36.3%

of hypertension claims granted overall vs. in decisions that mention Agent Orange or other herbicides

13.0%→43.0%

of herbicide-list claims granted for Johnston Atoll veterans in 2020-2021 vs. 2023-2025

23.7%→11.4%

of herbicide-list claims granted for all veterans vs. in decisions that name Fort Ord

22.3%→32.7%

of diabetes claims granted for all veterans vs. in decisions that name Vietnam

4.8%→68.8%

of hip claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

2.7%→87.3%

of radiculopathy claims granted when the back was not granted in the same decision vs. when it was

22.6%→38.1%

of anxiety claims granted overall vs. when claimed secondary to service-connected PTSD

4.9%→70.4%

of neck claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

23.7%→27.2%

of herbicide-list claims granted for all veterans vs. in decisions that name the Philippines

34.4%→42.1%

of coronary artery disease claims granted for all veterans vs. in decisions that name Vietnam

17.6%→39.7%

of erectile dysfunction claims granted overall vs. when claimed secondary to a genitourinary cancer

2.9%→59.2%

of hearing loss claims granted with neither noise exposure discussed nor a positive nexus opinion vs. with both

7.0%→47.9%

of all Board decisions vs. decisions that name Puerto Rico mention the National Guard or reserves

31.2%→39.1%

of prostate cancer claims granted for all veterans vs. in decisions that name Vietnam

20.0%→48.8%

of GERD claims granted overall vs. when claimed secondary to a service-connected knee condition

24.5%→43.5%

of herbicide-list claims granted for all veterans vs. in decisions that name the Korean DMZ

22.3%→5.3%

of diabetes claims granted for all veterans vs. in decisions that name Panama

4.7%→74.9%

of shoulder claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

14.5%→70.7%

of hypertension claims granted in decisions that name Vietnam, 2020 vs. 2023

38.2%→63.2%

of depression claims granted overall vs. when claimed secondary to service-connected PTSD

11.1%→52.5%

of herbicide-list claims granted for Guam veterans in 2020-2021 vs. 2023-2025

26.8%→34.5%

of IBS claims granted for all veterans vs. in decisions that name Gulf War service

6.5%→74.9%

of knee claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

20.0%→13.6%

of diabetes claims granted for all veterans vs. in decisions that name Okinawa

5.3%→80.3%

of back claims granted with neither a credibility finding nor a positive nexus opinion vs. with both

24.3%→45.3%

of sinusitis and rhinitis claims granted for all veterans vs. in decisions that record burn pit exposure

23.1%→13.2%

of claims granted: all veterans with the same conditions vs. Fort McClellan veterans

30.9%→45.2%

of migraine claims granted overall vs. when claimed secondary to service-connected depression

24.6%→45.3%

of sleep apnea claims granted overall vs. when claimed secondary to a service-connected knee condition

5.2%→48.7%

of TBI claims granted with neither combat service nor a positive nexus opinion vs. with both

13

of the 15 most-decided conditions were granted more often in 2025 than in 2018

33.5%→32.1%

of claims for the eight presumed conditions granted for all veterans vs. for Camp Lejeune veterans

35.5%→74.0%

of Parkinson's claims granted overall vs. in decisions that name a Thai air base

5.3%→84.7%

of PTSD claims granted with neither a verified stressor nor a positive nexus opinion vs. with both

20.0%→64.7%

of diabetes claims granted overall vs. in decisions that name a Thai air base

30.3%→63.1%

of infantry veterans' claims granted at the Board: hearing loss, then tinnitus

16.2%→34.5%

of radiculopathy decisions granted, 2018–2019 to 2024–2025

27.9%→47.4%

of sciatic nerve claims secondary to a back condition granted, 2018–2019 to 2024–2025

32.4%→56.3%

of sleep apnea claims secondary to a knee condition granted, 2018–2019 to 2024–2025

10.7%→24.3%

of hypertension decisions granted, 2018–2019 compared with 2024–2025

27.9%→55.9%

of radiculopathy claims secondary to a back condition granted, 2018–19 to 2024–25

41.4%→65.7%

granted, compared with all tinnitus decisions at the Board

22.6%→47.8%

of sleep apnea claims secondary to PTSD granted, 2018 to 2026

35.5%→88.4%

granted on the merits, without and with a positive nexus opinion

46.0%→58.1%

of issues remanded, direct claims and secondary claims